Search Results for “”

Endocrine diseases are highly common, but often missed early on due to subtle and variable symptoms. The 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines are out now , including helpful resources to demystify these complex and confusing cases for your whole team. 

Mentorship for new positions, transitions, and those later in their careers? Why not, says Melody Martinez, CVT, who served on the 2023 AAHA Mentoring Guidelines task force. She talks to Central Line about the value of a mentor at any stage of life.

Based on the AAHA 2022 Pain Management Guidelines , the new certificate course helps every team member better understand pain in dog and cat patients, giving everyone a common language to spot and treat pain better.

A multimillion-dollar gift to the University of Florida Veterinary Oncology Program and Colorado State University from the estate of Lawrence G. Laiks—a dentist—and his wife Ann Laiks, who was a dental assistant, could be a game-changer in the fight against cancer in animals and humans.

As 2019 draws to a close and we look back over the year that was, NEWStat put together a list of the most popular news stories we published over the last 12 months. 

This week: A frostbitten cat gets 3D-printed paws, a con man peddling canine-cancer cures gets caught, and a veterinary school that admits rejected candidates . . . for a price.

As we kick off a new year, let’s take a look back at our top stories from 2021.  

Ready to improve your practice’s diabetes management game? AAHA’s newly revised Diabetes Management Guidelines feature a robust resource center full of mobile-friendly tools and educational materials to empower practitioners and pet owners alike.

This week: checking for microchips becomes law in New York, why more dogs aren't sniffing out cancer, and nipping compassion fatigue in the bud

The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.